ClinicalTrials.gg
CompletedNCT05784857Updated Nov 17, 2026

The Effect of Touch Methods on Pain and Physiological Parameters in Preterm Infants During Endotracheal Aspiration

An interventional study of Touch Methods in Preterm, Pain and Infant ALL, sponsored by Acibadem University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 24 Weeks to 37 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Acibadem University · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 17, 2026Now CompletedFirst site in Turkey (Türkiye)+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Not applicable
Ages
24 Weeks to 37 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Premature Birth by Acibadem University — 1 open to participants now, 1 under way, none of them phase 3. Premature Birth · Acibadem University.

Started
2023
with 2 others
No phase
9 of 11
1 open now
Registered
6th of 11
by date

Among the 11 studies in Premature Birth by Acibadem University, this one is one of 3 that started in 2023, is one of 9 with no phase, and was the 6th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

1 of the 11 studies in Premature Birth by Acibadem University is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 24 Weeks to 37 Weeks · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Premature Birth by Acibadem University, or all of them as a file.
02

Study summary

Recurrent and painful interventions such as heel lancing, venipuncture, dressing change, endotracheal aspiration are frequently performed in neonatal intensive care units (NICU). Touch is one of the infant's earliest developing senses. Therefore it is very important among individualized supportive care practices. Correct stimulation of the infant's sense of touch affects psychosocial development positively. In addition, it is reported that touch has a calming and analgesic effect during invasive interventions. Therefore, there is a need for touch appropriate for development of newborn.

The aim of this study was determine the effect of Yakson and Gentle Human Touch on pain and physiologic parameters in preterm infants during endotracheal aspiration.

Read the detailed description

It was designed as a prospective, quasi-experimental.In this study, each intubated infant will be followed up during 3 aspiration procedures. The first aspiration procedure will be performed without intervention. During the second and third aspiration procedure, yakson and gentle touch will be applied, respectively.Physiological parameters and pain score of newborn will be evaluated before, during and immediately after aspiration.

Yakson touch: Yakson touch is defined in traditional Korean culture as a kind of therapeutic touch that a mother believes will treat her sick child by stroking it with a compassionate, sincere and loving attitude. The Yakson protocol was developed by Im and Kim (2009) in an understandable form that can be easily implemented. While newborn is in supine position, practitioner applies Yakson touch. The Yakson touch method continue for 15 minutes with steady touch (5 minutes), compassionate caressing (5 minutes), and repetition of steady touch (5 minutes). In this method, the palms of the practitioner and all fingers keep in close contact so that the babies don't feel pressure.

  1. Steady touch (5 minutes): One hand rest on the chest and abdomen of the preterm infant, while the other hand support the back and hip of the preterm infant.
  2. Compassionate Caress (5 minutes): In the same hand position, the practitioner repeat caressing and resting for 5 minutes: Caress (1 minutes), rest (30 seconds), caress (1 minutes), rest (30 seconds), and caress (2 minutes). The practitioner caress the infants' chest and belly with a 1 cm diameter clockwise circular movement every 10 second.
  3. Steady touch (5 minutes): The practitioner follow the steady touch procedure as previously describe.

Gentle Human Touch: Gentle human touch refers to steady contact of the skin without caressing or massaging. While the practitioner place one hand on the crown of the preterm infant on the eyebrow line with the fingertip touch for 15 minutes, the other hand was place on the lower abdomen covering the waist and hip of the infants.

03

Conditions studied

  • Preterm
  • Pain
  • Infant ALL

Keywords

  • touch
  • preterm infant
  • pain
04

Who can participate

Ages eligible
24 Weeks to 37 Weeks
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The gestational week of the infant is less than 38
  • Absence of congenital anomaly
  • Mechanical ventilator support
  • Absence of comorbid disease
  • Not having undergone surgery
  • No analgesic medication has been administered in the last hour

Exclusion criteria

Exclusion Criteria:

  • Infants with diseases such as sepsis that interfere with the application of touch technique
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • Other
    No Intervention and Touch Group

    Each intubated infant will be follewed up during 3 aspiration procedures. Different touching techniques will be used for preterm infants in each aspiration application. The first aspiration procedure will be performed without intervention. During the second aspiration procedure, yakson touch will be applied.Third aspiration procedure, gentle human touch will be applied.

    Other: Touch Methods

Interventions

  • OtherTouch Methods

    The Yakson touch method continue for 15 minutes with steady touch (5 minutes), compassionate caressing (5 minutes), and repetition of steady touch (5 minutes). In this method, the palms of the practitioner and all fingers keep in close contact so that the babies don't feel pressure. Gentle human touch refers to steady contact of the skin without caressing or massaging. While the practitioner place one hand on the crown of the preterm infant on the eyebrow line with the fingertip touch for 15 minutes, the other hand was place on the lower abdomen covering the waist and hip of the infants.

06

What researchers measure

Primary outcomes

  1. Change in Pain Score

    Pain will be evaluated using the Neonatal Pain Agitation and Sedation Scale (N-PASS).This scale was developed for preterm and term babies. The Turkish validity and reliability study was conducted in 2017. Crying, irritability, behavior-state, facial expression, extremity tone, and vital signs parameters are evaluated in the N-PASS scale. In this scale is evaluated with triple likert type and pain score can be between "0" and "10". Permission was obtained from the authors to use the scale.

    Time frame: Data will be collected from 5 minutes before the aspiration up to the 15th minute. Change in this time intervals will be assessed during 15 minutes.

  2. Change in Oxygen saturation

    Oxygen saturation will be evaluated using the pulse oximeter

    Time frame: Data will be collected from 5 minutes before the aspiration up to the 15th minute. Change in this time intervals will be assessed during 15 minutes.

  3. Change in Heart rate

    Heart rate will be evaluated using the monitor

    Time frame: Data will be collected from 5 minutes before the aspiration up to the 15th minute. Change in this time intervals will be assessed during 15 minutes.

07

Study locations

1 site
08

References and documents

Publications

  • Nist MD, Robinson A, Harrison TM, Pickler RH. An integrative review of clinician-administered comforting touch interventions and acute stress responses of preterm infants. J Pediatr Nurs. 2022 Nov-Dec;67:e113-e122. doi: 10.1016/j.pedn.2022.08.020. Epub 2022 Sep 20. PubMed 36137912 ↗
  • Dur S, Caglar S, Yildiz NU, Dogan P, Guney Varal I. The effect of Yakson and Gentle Human Touch methods on pain and physiological parameters in preterm infants during heel lancing. Intensive Crit Care Nurs. 2020 Dec;61:102886. doi: 10.1016/j.iccn.2020.102886. Epub 2020 Jun 27. PubMed 32601011 ↗
  • Im H, Kim E. Effect of Yakson and Gentle Human Touch versus usual care on urine stress hormones and behaviors in preterm infants: a quasi-experimental study. Int J Nurs Stud. 2009 Apr;46(4):450-8. doi: 10.1016/j.ijnurstu.2008.01.009. Epub 2008 Mar 18. PubMed 18353332 ↗
  • Bahman Bijari B, Iranmanesh S, Eshghi F, Baneshi MR. Gentle Human Touch and Yakson: The Effect on Preterm's Behavioral Reactions. ISRN Nurs. 2012;2012:750363. doi: 10.5402/2012/750363. Epub 2012 Jun 25. PubMed 22792482 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2023 to primary completion in Jan 2026, 32 months.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 32 months is above that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: start Feb 2023 → May 2023, primary completion Jul 2025 → Jan 2026 and completion Jul 2025 → Jan 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2023
First posted
Mar 27, 2023
StartActual
May 2, 2023was Feb 2023
Primary completionActual
Jan 2, 2026was Jul 2025
CompletionActual
Jan 2, 2026was Jul 2025
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 17, 2026
Sites
1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
Show site
  • Acibadem Health Group Ataşehir Hospital · Istanbul, Turkey (Türkiye)
Show 1 removed
  • Acibadem Health Group Ataşehir Hospital · İstanbul, Turkey
Nov 17, 2026
Start date
Feb 24, 2023→May 2, 2023
Nov 17, 2026
Primary completion
Jul 1, 2025→Jan 2, 2026 (actual)
Nov 17, 2026
Study completion
Jul 1, 2025→Jan 2, 2026 (actual)
Nov 17, 2026
Enrollment
81 (estimated)→82 (actual)
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Recruiting→Completed
    1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
    Show site
    • Acibadem Health Group Ataşehir Hospital · Istanbul, Turkey (Türkiye)
    Show 1 removed
    • Acibadem Health Group Ataşehir Hospital · İstanbul, Turkey
    Start date Feb 24, 2023→May 2, 2023
    Primary completion Jul 1, 2025→Jan 2, 2026 (now actual)
    Study completion Jul 1, 2025→Jan 2, 2026 (now actual)
    Enrollment 81 (estimated)→82 (actual)
    + 4 other changes: verification date, oversight details, contact details and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05784857
Responsible party
Zehra Kan Onturk (Assist. Prof., Acibadem University) — Principal investigator
First posted
Mar 27, 2023
Start date
May 2, 2023
Primary completion
Jan 2, 2026
Completion
Jan 2, 2026
Last update
Nov 17, 2026

Study contacts

Zehra Kan Öntürk, Assist Prof
principal investigator · Acibadem University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion